Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Top 10 Gold ETFs in 2025

Red Mountain Mining Successfully Lists on the US...

Copper Quest Exploration

Mineral Resource Estimate Updated for the Cowboy State...

Hydrogeological Testing Underway at Lo Herma

East Star and Endeavour Mining to Collaborate on...